Orthofix Medical Inc. (NASDAQ:OFIX) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Orthofix Medical Inc. (NASDAQ:OFIX) have earned an average recommendation of “Moderate Buy” from the six analysts that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $21.50.

A number of research analysts recently commented on OFIX shares. Stifel Nicolaus initiated coverage on Orthofix Medical in a research note on Tuesday, October 28th. They issued a “buy” rating and a $22.00 target price on the stock. Barrington Research increased their price objective on Orthofix Medical from $17.00 to $18.00 and gave the company an “outperform” rating in a research report on Wednesday, November 5th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Orthofix Medical in a report on Wednesday, October 8th.

Orthofix Medical Stock Performance

Orthofix Medical stock opened at $15.49 on Monday. Orthofix Medical has a fifty-two week low of $10.24 and a fifty-two week high of $20.48. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.38 and a current ratio of 2.47. The stock has a market cap of $613.40 million, a P/E ratio of -5.11 and a beta of 0.82. The firm’s fifty day moving average price is $15.31 and its 200-day moving average price is $13.57.

Institutional Investors Weigh In On Orthofix Medical

A number of hedge funds have recently made changes to their positions in the business. CWM LLC boosted its stake in shares of Orthofix Medical by 99.0% in the 3rd quarter. CWM LLC now owns 1,920 shares of the medical device company’s stock valued at $28,000 after purchasing an additional 955 shares in the last quarter. State of Alaska Department of Revenue bought a new stake in Orthofix Medical in the third quarter worth $30,000. US Bancorp DE lifted its stake in Orthofix Medical by 684.6% in the first quarter. US Bancorp DE now owns 5,673 shares of the medical device company’s stock worth $93,000 after purchasing an additional 4,950 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Orthofix Medical during the second quarter valued at about $147,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in shares of Orthofix Medical by 32.6% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 13,297 shares of the medical device company’s stock valued at $148,000 after buying an additional 3,271 shares during the last quarter. 89.76% of the stock is currently owned by institutional investors.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.